|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2003-11-10
|
|
pubmed:abstractText |
The risk of cardiovascular disease in hemodialysis patients is far greater than in the general population. Endothelial progenitor cells (EPCs) circulating in the peripheral blood contribute to neovascularization in the ischemic tissue. EPCs are considered to be included in CD34 positive (CD34+) or AC133 positive (AC133+) mononuclear cells (MNCs). This study's aim was to determine the number and functional activity of EPCs in hemodialysis patients and age-matched control subjects.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0300-7995
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
19
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
627-33
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14606986-Antigens, CD34,
pubmed-meshheading:14606986-Cardiovascular Diseases,
pubmed-meshheading:14606986-Endothelium, Vascular,
pubmed-meshheading:14606986-Female,
pubmed-meshheading:14606986-Flow Cytometry,
pubmed-meshheading:14606986-Hematopoietic Stem Cells,
pubmed-meshheading:14606986-Humans,
pubmed-meshheading:14606986-Immunoenzyme Techniques,
pubmed-meshheading:14606986-Male,
pubmed-meshheading:14606986-Middle Aged,
pubmed-meshheading:14606986-Multivariate Analysis,
pubmed-meshheading:14606986-Renal Dialysis,
pubmed-meshheading:14606986-Risk Factors,
pubmed-meshheading:14606986-Uremia,
pubmed-meshheading:14606986-Vascular Endothelial Growth Factor A
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Circulating endothelial progenitor cells are reduced in hemodialysis patients.
|
|
pubmed:affiliation |
Division of Cardiovascular Medicine, Jichi Medical School, Tochigi, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
